These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 15588120)

  • 1. An algorithmic computerised order entry approach to assist in the prescribing of new therapeutic agents: case study of activated protein C at an academic medical centre.
    Fischer MA; Lilly CM; Churchill WW; Baden LR; Avorn J
    Drug Saf; 2004; 27(15):1253-61. PubMed ID: 15588120
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Computerised provider order entry and residency education in an academic medical centre.
    Wong B; Kuper A; Robinson N; Morra D; Etchells E; Wu R; Shojania K
    Med Educ; 2012 Aug; 46(8):795-806. PubMed ID: 22803757
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Return on investment for a computerized physician order entry system.
    Kaushal R; Jha AK; Franz C; Glaser J; Shetty KD; Jaggi T; Middleton B; Kuperman GJ; Khorasani R; Tanasijevic M; Bates DW;
    J Am Med Inform Assoc; 2006; 13(3):261-6. PubMed ID: 16501178
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The use of computerized physician order entry with clinical decision support reduces practice variance in ordering preoperative investigations: A retrospective cohort study.
    Sim EY; Tan DJA; Abdullah HR
    Int J Med Inform; 2017 Dec; 108():29-35. PubMed ID: 29132628
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost-effectiveness of an electronic medication ordering system (CPOE/CDSS) in hospitalized patients.
    Vermeulen KM; van Doormaal JE; Zaal RJ; Mol PG; Lenderink AW; Haaijer-Ruskamp FM; Kosterink JG; van den Bemt PM
    Int J Med Inform; 2014 Aug; 83(8):572-80. PubMed ID: 24929633
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug use in academic medical centres in an era of ferment.
    Avorn J
    Pharmacoeconomics; 1996; 10 Suppl 2():124-9. PubMed ID: 10163429
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drotrecogin alfa (recombinant human activated protein C) in severe sepsis--a New Zealand viewpoint.
    Liang J; Streat S; Torrance J; Sleigh J; Freebairn R; Ramsay M
    N Z Med J; 2003 Sep; 116(1181):U586. PubMed ID: 14581969
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drotrecogin alfa (activated): a pharmacoeconomic review of its use in severe sepsis.
    Frampton JE; Foster RH
    Pharmacoeconomics; 2004; 22(7):445-76. PubMed ID: 15137883
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The analysis of physicians' work: announcing the end of attempts at in vitro fertilization].
    Santiago-Delefosse M; Cahen F; Coeffin-Driol C
    Encephale; 2003; 29(4 Pt 1):293-305. PubMed ID: 14615699
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A process for developing community consensus regarding the diagnosis and management of attention-deficit/hyperactivity disorder.
    Foy JM; Earls MF
    Pediatrics; 2005 Jan; 115(1):e97-104. PubMed ID: 15629972
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluating inter-professional work support by a computerized physician order entry (CPOE) system.
    Niazkhani Z; Pirnejad H; de Bont A; Aarts J
    Stud Health Technol Inform; 2008; 136():321-6. PubMed ID: 18487751
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The use of interactive computerized order sets to improve outcomes.
    Peshek SC; Cubera K; Gleespen L
    Qual Manag Health Care; 2010; 19(3):239-47. PubMed ID: 20523262
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Addressing innovative off-label medication use at an academic medical center.
    Skledar SJ; Corman SL; Smitherman T
    Am J Health Syst Pharm; 2015 Mar; 72(6):469-77. PubMed ID: 25736942
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Review of Nonformulary Medication Approvals in an Academic Medical Center.
    Her QL; Amato MG; Seger DL; Gilmore JF; Fanikos J; Fiskio JM; Bates DW
    Jt Comm J Qual Patient Saf; 2017 Feb; 43(2):89-96. PubMed ID: 28334567
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Benefit-risk assessment of drotrecogin alfa (activated) in the treatment of sepsis.
    De Backer D
    Drug Saf; 2007; 30(11):995-1010. PubMed ID: 17973539
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An economic evaluation of activated protein C treatment for severe sepsis.
    Manns BJ; Lee H; Doig CJ; Johnson D; Donaldson C
    N Engl J Med; 2002 Sep; 347(13):993-1000. PubMed ID: 12324556
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence-based clinical guidelines in Kyrgyz Republic.
    Zurdinova AA
    Int J Risk Saf Med; 2015; 27 Suppl 1():S45-6. PubMed ID: 26639705
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Physicians' response to guided geriatric dosing: initial results from a randomized trial.
    Peterson JF; Rosenbaum BP; Waitman LR; Habermann R; Powers J; Harrell D; Miller RA
    Stud Health Technol Inform; 2007; 129(Pt 2):1037-40. PubMed ID: 17911873
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decision support systems in clinical practice: The case of venous thromboembolism prevention.
    Nazarenko GI; Kleymenova EB; Payushik SA; Otdelenov VA; Sychev DA; Yashina LP
    Int J Risk Saf Med; 2015; 27 Suppl 1():S104-5. PubMed ID: 26639683
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early goal-directed therapy, corticosteroid, and recombinant human activated protein C for the treatment of severe sepsis and septic shock in the emergency department.
    Nguyen HB; Corbett SW; Menes K; Cho T; Daugharthy J; Klein W; Wittlake WA
    Acad Emerg Med; 2006 Jan; 13(1):109-13. PubMed ID: 16365336
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.